SPRYCEL-100mg. (Dasatinib Tablet) 100mg

SPRYCEL 100mg tablets contain dasatinib, a prescription medication used to treat certain blood cancers. This oral therapy helps manage chronic myeloid leukemia and acute lymphoblastic leukemia. Store below 25°C and keep out of reach of children. Not for self-use without medical supervision.

Strength

100mg

Pack Size

30s

Storage

Below 25°C

Manufacturer / TM Owner

E.R. Squibb & Sons, L.L.C.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Dasatinib is prescribed for adults with Philadelphia chromosome-positive chronic myeloid leukemia (CML) in chronic, accelerated, or blast phases. It is also used to treat Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL) in adults who no longer respond to prior therapies. This medication works by targeting abnormal proteins that drive cancer cell growth.

Side Effects

Many patients experience improved energy levels and reduced symptoms as treatment progresses. Some may notice changes in appetite or mild gastrointestinal discomfort. These effects vary and do not indicate treatment success or failure. Regular monitoring helps assess individual responses.

Precautions & Warnings

Keep dasatinib tablets in their original packaging and store below 25°C. Avoid exposure to moisture or direct sunlight. Do not crush, split, or chew the tablets. Always use the medication as directed by a healthcare professional and attend scheduled follow-up appointments.

Avoid Interactions

Certain medications, including some antibiotics and antifungals, may affect how dasatinib works. Avoid grapefruit products and alcohol unless approved by a doctor. Inform your healthcare provider about all prescription, over-the-counter, and herbal products you are using before starting treatment.

Frequently Asked Questions

Dasatinib is used to treat certain types of blood cancers, including chronic myeloid leukemia and acute lymphoblastic leukemia.

Store dasatinib tablets below 25°C in their original packaging, away from moisture and direct light.

Follow your doctor’s instructions regarding food intake, as it may affect absorption.

Avoid grapefruit products and alcohol unless cleared by your healthcare provider.

Long-term safety depends on individual health factors; regular medical monitoring is required.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.